SANSONE GUY P 4

What Happened Guy P. Sansone, a director of Pediatrix Medical Group, Inc. (MD), was granted 7,196 restricted shares as an annual equity award on May 7, 2026. The Form 4 reports the acquisition price as $0 (grant), so the filing lists total consideration of $0. These are compensation awards rather than open‑market purchases or sales.

Key Details

• Transaction date: 2026-05-07 (reported on Form 4 filed 2026-05-11). Filing appears timely (within required business days).
• Transaction type: Award/Grant (code A) of 7,196 restricted shares; acquisition price reported $0.
• Vesting: Shares will vest on May 7, 2027 (per footnote).
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnotes/Exhibits: Grant made under the Issuer's Amended and Restated 2008 Incentive Compensation Plan; Exhibit 24.1 (Power of Attorney) attached.

Context Restricted share grants are a common form of director compensation and usually vest over time; they do not represent an immediate market purchase or sale and may be forfeited if vesting conditions are not met. The $0 reported acquisition price reflects that no cash changed hands at grant — the economic value will depend on the stock price at vesting and any tax treatment at that time.